Sleep initiation and maintenance disorders — compounds assessed
The 2 compounds the Institute assesses in sleep initiation and maintenance disorders.
§4Compounds assessed
Compounds the Institute assesses in this indication, with the class of each and its overall certainty. A compound appears here whether or not the evidence supports its use, because recording that a compound has been studied and found wanting is as much part of the assessment as recording that one has not.
-
Small historical studies reported inconsistent effects on sleep architecture; the effect that gave the peptide its name has not been reliably reproduced — The Institute assesses this as very low certainty and notes specifically that the balance of the…
Very low -
No assessable randomised evidence identified — —
Very low
References cited on this page
References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.
- D’Hondt M, Bracke N, Taevernier L, Gevaert B, Verbeke F, Wynendaele E, De Spiegeleer B. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis 2014;101:2–30. doi:10.1016/j.jpba.2014.06.012 · PMID 25044089
Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.